POM34 Antibody

What is POM34 and where is it located in cells?

POM34 (Pore Membrane protein 34) is an integral membrane protein localized to nuclear pore complexes (NPCs) in Saccharomyces cerevisiae. It is a double-pass transmembrane protein with both amino (N) and carboxy (C) termini positioned on the cytosolic/pore face of the nuclear envelope . POM34 plays important roles in nuclear pore complex structure and function, contributing to nucleocytoplasmic transport processes. The protein is embedded in the pore membrane domain of the nuclear envelope, which is continuous with the endoplasmic reticulum membrane system.

What is the membrane topology of POM34?

POM34 features a dual transmembrane domain architecture. Detailed membrane topology analysis reveals that POM34 contains two transmembrane segments (TM1, residues 62-85 and TM2, residues 129-153) that span the nuclear envelope membrane . Both the N-terminal (residues 4-54) and C-terminal (residues 161-299) regions are positioned on the cytoplasmic/pore side rather than in the lumen of the nuclear envelope . This topology has been experimentally verified through glycosylation assays using Suc2p fusion proteins and alkaline extraction experiments, which demonstrated that neither terminus is glycosylated when placed in the context of a glycosylation reporter construct .

How does POM34 anchor to the nuclear membrane?

Both transmembrane segments (TM1 and TM2) of POM34 are essential for its proper membrane integration. Experimental deletion of either TM1 (amino acids 62-85) or TM2 (amino acids 129-153) results in failed membrane integration, as demonstrated by alkaline extraction experiments . When either transmembrane segment is deleted, the protein is extracted from the membrane fraction and found in the supernatant, unlike wild-type POM34 which remains exclusively in the membrane pellet fraction during alkaline extraction procedures . This indicates that both transmembrane domains work cooperatively to anchor POM34 in the nuclear pore membrane.

What epitopes should be targeted when designing POM34 antibodies?

For optimal detection of POM34, antibodies should be raised against either the N-terminal (amino acids 4-54) or C-terminal (amino acids 161-299) domains, as both regions are exposed to the cytoplasm/pore side and are thus accessible to antibodies in fixed cell preparations . These regions are hydrophilic and contain unique sequences that distinguish POM34 from other pore membrane proteins. Avoid generating antibodies against the transmembrane domains (residues 62-85 and 129-153) as these regions are embedded in the lipid bilayer and may be inaccessible . For experiments requiring domain-specific detection, separating N-terminal vs. C-terminal recognition can provide valuable insights into protein orientation and topology.

What methods can be used to validate POM34 antibody specificity?

A comprehensive validation strategy for POM34 antibodies should include:

• Western blotting on wild-type vs. pom34Δ strains - A specific antibody should detect a ~34 kDa band in wild-type extracts that is absent in the deletion strain

• Immunoprecipitation followed by mass spectrometry - Confirm that POM34 is the primary protein pulled down

• Immunofluorescence microscopy - Verify nuclear rim staining pattern characteristic of NPCs, which should be absent in pom34Δ strains

• Cross-reactivity testing - Ensure the antibody doesn't detect related pore membrane proteins, particularly POM152, which has some functional overlap with POM34

• Epitope mapping - Confirm recognition of specific domains using deletion constructs like those described in the research (Pom34p-ΔN, Pom34p-ΔC, etc.)

How can POM34 antibodies be used to study nuclear pore complex assembly?

POM34 antibodies provide valuable tools for studying NPC assembly through several methodological approaches:

• Immunofluorescence time-course studies - Monitor POM34 recruitment during NPC assembly phases in synchronized cells

• Proximity-based labeling experiments - Use POM34 antibodies in conjunction with other NPC component antibodies to track spatial relationships during assembly

• Co-immunoprecipitation experiments - Identify interacting partners during different stages of NPC assembly

• Super-resolution microscopy - Define precise localization within the NPC structure using fluorophore-conjugated antibodies

• Chromatin immunoprecipitation (ChIP) - Investigate whether POM34 associates with specific chromatin regions during nuclear envelope reformation after mitosis

The methodology should be carefully designed to distinguish between mature NPCs and assembly intermediates, particularly in strains with genetic interactions such as pom34Δ nup188Δ that show perturbed NPC structure .

What nucleoporins functionally interact with POM34?

POM34 exhibits a complex network of genetic interactions with multiple nucleoporins spanning different structural elements of the nuclear pore complex. The most significant functional interactions have been established with:

Notably, POM34 does not show significant genetic interactions with nucleoporins exclusively localized to the nucleoplasmic face of the NPC (Nup1p, Nup2p, Nup60p) . These genetic data suggest that POM34 antibodies could be particularly valuable for investigating the assembly and maintenance of specific NPC subcomplexes.

What is the functional relationship between POM34 and POM152?

POM34 and POM152 exhibit a complex functional relationship characterized by:

• Shared genetic interactions: Both proteins show synthetic lethality with mutations in NUP59, NUP170, and NUP188

• Non-essential redundancy: The pom34Δ pom152Δ double mutant is viable at all temperatures and shows no significant defects in NPC structure or function

• Partial suppression: Overexpression of POM152 can partially suppress the synthetic lethality of pom34Δ nup59Δ and pom34Δ nup170Δ double mutants, suggesting some functional redundancy

• Non-reciprocal suppression: Interestingly, overexpression of POM34 does not rescue any pom152Δ nup double mutants, indicating asymmetric functional compensation

• Differential genetic requirements: POM152 overexpression suppresses some but not all pom34Δ synthetic lethal interactions (e.g., does not complement pom34Δ nup188Δ)

These findings indicate that while POM34 and POM152 share some functions in maintaining NPC structure, they also have distinct roles. Researchers using POM34 antibodies should consider the potential influence of POM152 when interpreting results, particularly in studies involving genetic manipulations that might trigger compensatory mechanisms.

How do mutations in POM34 affect nuclear transport pathways?

Disruptions in POM34 function, particularly in combination with other nucleoporin mutations, can significantly impact nuclear transport pathways. Research has shown:

• The pom34Δ nup188Δ double mutant exhibits perturbed NPC structure and function, including mislocalization of nucleoporins containing phenylalanine-glycine (FG) repeats

• Nuclear import capacity for the Kap104p and Kap121p transport pathways is specifically inhibited in the pom34Δ nup188Δ background

• Different POM34 domains contribute differentially to these transport functions, with the transmembrane domains plus either the N- or C-terminal region being necessary for function in different genetic backgrounds

When using POM34 antibodies to study transport defects, researchers should design experiments that can distinguish between direct effects on specific transport pathways versus indirect consequences of general NPC structural perturbations. Time-course experiments combining POM34 antibodies with transport cargo markers can be particularly informative.

What experimental approaches can be used to study POM34 domain functions?

Several complementary methodological approaches can be employed to investigate the function of specific POM34 domains:

• Domain deletion analysis: Creating constructs lacking specific regions (N-terminus, C-terminus, or transmembrane segments) and testing their ability to complement synthetic lethal phenotypes in various genetic backgrounds

• Domain swapping experiments: Exchanging domains between POM34 and other pore membrane proteins like POM152 to identify regions responsible for specific functions

• Site-directed mutagenesis: Introducing point mutations in conserved residues within each domain to identify essential amino acids

• Fusion protein analysis: Creating reporter fusions (such as the Suc2p fusions described) to study topology and localization of specific domains

• Immunoprecipitation with domain-specific antibodies: Using antibodies targeting different POM34 domains to identify domain-specific interaction partners

Research has shown that different POM34 domains are required in different genetic backgrounds. For example, both transmembrane domains plus either the N- or C-terminal region are necessary for function in various double mutant contexts, suggesting context-specific functional requirements .

How can researchers effectively immunoprecipitate POM34 from cellular extracts?

For successful immunoprecipitation of POM34 from yeast or other cellular extracts:

• Cell lysis optimization: Use gentle detergents (0.5-1% NP-40 or digitonin) to solubilize membrane proteins while preserving protein-protein interactions

• Membrane fraction enrichment: Perform subcellular fractionation to concentrate nuclear envelope membranes before solubilization

• Crosslinking considerations: For transient interactions, mild crosslinking (0.1-0.5% formaldehyde) may help preserve complexes

• Antibody selection: Choose antibodies targeting the cytoplasmic/pore-facing domains (N- or C-terminus) rather than transmembrane regions

• Validation controls: Always perform parallel immunoprecipitations from pom34Δ strains to identify non-specific binding

• Buffer composition: Include glycerol (5-10%) and appropriate salt concentration (100-150mM NaCl) to maintain protein stability and reduce non-specific interactions

For co-immunoprecipitation studies examining POM34 interactions with other nucleoporins, consider the membrane association of interaction partners. The differential genetic interactions observed with nucleoporins from various subcomplexes suggest that different buffer conditions may be optimal for capturing specific interactions .

What fixation and permeabilization methods are optimal for immunolocalization of POM34?

For optimal immunofluorescence detection of POM34 at the nuclear envelope:

• Fixation protocol:

  • For yeast: 4% formaldehyde for 15-30 minutes, as stronger fixatives may mask epitopes

  • For spheroplasting: Use zymolyase treatment under non-denaturing conditions

• Permeabilization options:

  • Digitonin (0.1-0.5%): Selectively permeabilizes plasma membrane while leaving nuclear envelope relatively intact

  • Triton X-100 (0.1-0.5%): Provides more complete permeabilization for access to all POM34 epitopes

• Epitope preservation considerations:

  • Avoid methanol fixation which can distort membrane proteins

  • Consider antigen retrieval steps if aldehyde fixation reduces antibody accessibility

• Blocking conditions:

  • Use 3-5% BSA or normal serum with 0.1% Tween-20 to reduce non-specific binding

  • Include competing peptides for any cross-reactive epitopes

• Co-localization markers:

  • Include antibodies against other NPC components (e.g., Nup188p, Nup170p) for validation

  • Use markers of the nuclear envelope (e.g., lamin in higher eukaryotes) for reference

Given the membrane topology of POM34 with both termini facing the cytoplasmic/pore side , accessibility to antibodies should be good with standard permeabilization methods, but optimization may be required for specific antibody preparations.

Why might POM34 antibodies show inconsistent results between different experimental systems?

Inconsistent results when using POM34 antibodies across different experimental systems may stem from several factors:

• Species-specific differences: POM34 is characterized primarily in Saccharomyces cerevisiae, and antibodies may not cross-react with homologs in other species despite sequence conservation

• Functional redundancy: As seen with POM152, other pore membrane proteins may compensate for POM34 in certain genetic backgrounds , potentially masking phenotypes

• Context-dependent domain requirements: Different domains of POM34 are required in different genetic backgrounds , which could affect epitope accessibility

• Post-translational modifications: Potential modifications might mask epitopes under certain cellular conditions

• NPC structural heterogeneity: The composition and structure of NPCs can vary between cell types and conditions, affecting POM34 integration and accessibility

To address these challenges, researchers should validate antibodies in each experimental system using appropriate controls (including pom34Δ strains), and consider using multiple antibodies targeting different POM34 epitopes to confirm results.

How can researchers distinguish between direct and indirect effects when studying POM34 mutant phenotypes?

Distinguishing direct from indirect effects in POM34 research requires careful experimental design:

• Temporal analysis: Use inducible or rapid degradation systems to monitor the immediate versus long-term consequences of POM34 depletion

• Domain-specific mutations: Compare phenotypes of different domain deletions, as some domains may be specifically required for certain functions

• Suppressor analysis: Test whether overexpression of functionally related proteins (like POM152) can rescue specific phenotypes but not others

• Quantitative phenotyping: Measure the severity of different phenotypes to identify primary versus secondary effects

• Epistasis analysis: Determine the phenotypic consequences of combining pom34 mutations with mutations in genes acting in suspected pathways

• Direct biochemical assays: Use purified components to reconstitute activities in vitro when possible

For example, while the pom34Δ nup188Δ mutant shows both NPC structural defects and inhibition of specific nuclear import pathways , careful analysis of the timing and severity of these phenotypes can help establish causality.

What controls should be included when interpreting POM34 antibody staining patterns?

For rigorous interpretation of POM34 immunostaining experiments, include these essential controls:

• Genetic controls:

  • pom34Δ strains should show complete absence of specific staining

  • Strains expressing POM34 fusion proteins with altered molecular weights should show corresponding shifts in Western blots

• Antibody specificity controls:

  • Peptide competition assays with the immunizing antigen

  • Secondary-only controls to detect non-specific binding

  • IgG isotype controls to identify Fc receptor interactions

• Co-localization standards:

  • Well-characterized NPC markers (e.g., mAb414 for FG nucleoporins)

  • Markers distinguishing NPCs from other nuclear envelope structures

• Fixation/permeabilization controls:

  • Compare multiple protocols to rule out fixation artifacts

  • Include controls for autofluorescence, particularly with aldehyde fixatives

• Cross-reactivity assessment:

  • Test antibody against other pore membrane proteins, particularly POM152 which has some functional overlap

  • Include strains overexpressing potential cross-reactive proteins

How can POM34 antibodies contribute to studying nuclear envelope dynamics during cell division?

POM34 antibodies offer unique opportunities for investigating nuclear envelope dynamics during mitosis and cell division:

• Live-cell imaging applications:

  • Using Fab fragments of POM34 antibodies conjugated to fluorophores for real-time tracking

  • Comparing POM34 dynamics with other NPC components to understand assembly/disassembly order

• Cell-cycle specific interactions:

  • Immunoprecipitation of POM34 at different cell cycle stages to identify temporally regulated binding partners

  • ChIP-seq approaches to determine if POM34 associates with specific chromosomal regions during nuclear envelope reformation

• Mitotic regulation studies:

  • Investigating potential post-translational modifications of POM34 during cell division

  • Examining how POM34's interactions with the inner ring nucleoporins (Nup170p, Nup188p, Nup59p) change during mitosis

• Genetic bypass analysis:

  • Determining whether the synthetic lethal interactions of POM34 are maintained or altered during specific cell cycle phases

  • Investigating whether POM152 overexpression can suppress POM34 deficiencies specifically during nuclear envelope reformation

These approaches can help address fundamental questions about NPC biogenesis and inheritance during cell division.

What emerging technologies can enhance POM34 antibody-based research?

Several cutting-edge technologies can significantly advance POM34 antibody-based research:

• Super-resolution microscopy:

  • STORM/PALM imaging to precisely localize POM34 within the NPC structure

  • Expansion microscopy to physically magnify cellular structures for enhanced visualization

• Proximity labeling approaches:

  • APEX2 or BioID fusions with POM34 to identify proteins in close proximity

  • Split-BioID systems to detect condition-specific interactions

• Single-molecule tracking:

  • Using fluorescently labeled antibody fragments to track individual POM34 molecules

  • Correlating POM34 dynamics with nuclear transport events

• Cryo-electron tomography:

  • Immunogold labeling with POM34 antibodies for structural studies

  • Correlative light and electron microscopy to link functional and structural data

• Engineered antibody formats:

  • Nanobodies or single-chain antibodies for improved penetration and reduced size

  • Bispecific antibodies to simultaneously detect POM34 and interacting partners

These technologies could help resolve outstanding questions about how POM34 contributes to NPC structure and function across different genetic backgrounds .